Future of Healthcare
Strategic debates on the future of healthcare, new therapies, AI, reimbursement policy and the transformation of care systems.
November 17, 2026
Warsaw, Polish History Museum
Poland's first platform combining debate on the future of healthcare with the translation and commercialisation of Polish medical innovations.
Special guest Galien Forum 2026
Science that changes the world.
Innovations that make a difference.
Dr Hayat Sindi is a globally recognised scientist, inventor and entrepreneur, Global Ambassador for the G20 Health & Development Partnership, UNESCO Goodwill Ambassador for Science, and an advocate for social innovation.
At Galien Forum 2026, Dr Sindi will deliver the keynote address “Science with Purpose”. In this personal and inspiring talk, she will trace her journey from a young girl passionate about science to an internationally respected scientist and global leader.
Drawing on her experience in academia, entrepreneurship, global health, international development, public service, and Saudi Arabia’s Shoura Council, Dr Sindi will share how curiosity, resilience and a commitment to serving others have shaped her belief that purpose drives meaningful innovation and lasting impact. Through stories from her career, she will explore how ideas can become solutions that change lives.
Her achievements have earned recognition from leading international institutions and media organisations. She received the Clinton Global Citizen Award for Leadership in Civil Society, was recognised through President Obama’s “Educate to Innovate” and “Million Minds” initiatives, was named to the BBC 100 Women list, and was recognised by Forbes as one of the most influential women in the Arab world.
The keynote will explore the intersection of science, health, and entrepreneurship, showing how discoveries can become practical innovations, sustainable ventures, and scalable solutions. Dr Sindi will highlight how purpose-driven leadership can address healthcare challenges while advancing economic growth, innovation, and social progress.
Relevant to entrepreneurs, healthcare professionals, researchers, business leaders, policymakers, and innovators, Science with Purpose will offer insights into aligning ambition with purpose, turning challenges into opportunities, and creating meaningful impact across health, business, and society.
Keynote · Galien Forum 2026
17 November 2026 09:40 - 10:25 · Warsaw
Join the ForumGalien Forum 2026
17 November 2026 · Polish History Museum, Warsaw
Discovery is only half of a breakthrough.
Breakthroughs are emerging in new parts of the world, and new capital is financing them. Therapies are changing prognosis faster than the system can keep up. The global map of medicine is being redrawn.
Galien Forum is one day on which the people setting the direction of global science and medicine meet those changing healthcare in Poland. They share one question: where is Poland’s place on this new map?
There are no classic moderated panels at Galien Forum. Each session opens with a short keynote, and invited experts then lead the conversation. We do not ask whether innovation is needed. We ask what happens once it is already here: what challenges it sets before clinicians, the payer and the system as a whole, and which of those questions still have no answer. Every panel ends with three recommendations for decisions in 2027.
For decades, it was clear where new medicines came from and who funded their development. Today, biotechnology — alongside chips and artificial intelligence — has become a strategic technology. China and the Gulf states are joining the leaders, while global pharmaceutical companies are investing in scientific discoveries at ever earlier stages. Who will shape the direction of medicine over the next decade? Where is value being created in pharmaceutical innovation today? And what place can Poland secure in this new landscape?
Invited experts
Prof. dr hab. n. med. Cezary Szczylik
Oncologist and specialist in clinical oncology, Co-Chair of the Prix Galien Poland Jury.
Katarzyna Kęcka
Undersecretary of State at the Ministry of Health.
Maciej Bagiński
President of the Management Board, Polish Humanitarian Action.
Tomasz Hildt
Regional Director, The Galien Foundation CEE & Middle East, responsible for international cooperation in medical innovation.
How can scientific discoveries become practical innovations, sustainable ventures and solutions that change lives? Dr Hayat Sindi, UNESCO Goodwill Ambassador for Science and Global Ambassador for the G20 Health & Development Partnership, will explore the intersection of science, health and entrepreneurship, showing how purpose-driven leadership can create lasting impact.
Virtual wards in the United Kingdom, hospital-at-home care in the United States, outcomes-based payment in Sweden: models of care that still sound futuristic in Poland are already operating elsewhere. Which of them make sense in the Polish context? What needs to change to put them into practice? How will the roles of hospitals, doctors and patients evolve, and what will healthcare teams need to learn?
Invited experts
Prof. dr hab. n. med. Wojciech Fendler
Head of the Department of Biostatistics and Translational Medicine at the Medical University of Łódź and visiting professor at the Dana-Farber Cancer Institute in Boston. President of the Medical Research Agency, 2024–2026, and Co-Chair of the Prix Galien Poland Jury.
Prof. dr hab. n. med., dr h.c. mult., FESC Krzysztof J. Filipiak
Cardiologist, internist, hypertension specialist and clinical pharmacologist. Director-Rector of the Centre of Postgraduate Medical Education. Member of the Board of Directors of the International Society of Cardiovascular Pharmacotherapy. Member of the Committee of Clinical Sciences and the Committee of Physiological and Pharmacological Sciences of the Polish Academy of Sciences.
Mateusz Oczkowski
Director of the Department of Drug Policy and Pharmacy at the Ministry of Health and Chair of the Economic Commission.
Polish pharmaceutical companies are expanding into global markets, acquiring plants abroad and building international manufacturing networks. What allows them to grow globally while still developing capabilities and investing in Poland? And why is it so difficult to turn the potential of Polish science into innovations that become the foundation of strong, competitive companies? The panel will look at what determines success along this path: from collaboration between science and industry and the financing of development to the role of the state in creating the conditions for commercialising and scaling innovation.
Invited experts
Prof. dr hab. n. farm. Agata Przekora-Kuśmierz
Biotechnologist and expert in tissue engineering and biomaterials. Professor at the Institute of Pharmaceutical Sciences of the John Paul II Catholic University of Lublin.
Dr hab. Małgorzata Gałązka-Sobotka
Rector of Lazarski University, Dean of Lazarski Executive Education and Director of the Institute of Healthcare Management at Lazarski University. Director of the “MBA in Healthcare” programme. From 2015 to 2025, Vice-Chair of the Council of the National Health Fund.
Aleksandra Czok
Director of the Strategic Marketing Department at Adamed Pharma.
Wojciech Dołkowski
Co-founder and President of MEDtube, an international medical education platform.
Until recently, half of all people with cystic fibrosis in Poland did not live to the age of 25, while most children with the most severe form of SMA did not survive to their second birthday without permanent ventilatory support. Today, the first generation of patients receiving new therapies are completing their education, working and planning families. Which clinical questions can medicine still not answer? How do we measure the value of a therapy that transforms a patient’s entire life? And who will guide these patients through adulthood?
Invited experts
Prof. dr hab. n. med. Dorota Sands
Head of the Cystic Fibrosis Treatment Centre in Dziekanów Leśny, specialist in paediatrics and pulmonology, and an expert in the treatment of cystic fibrosis.
Prof. dr hab. n. med. Urszula Demkow
Head of the Department of Laboratory Diagnostics and Clinical Immunology of Developmental Age at the Medical University of Warsaw. Specialist in internal medicine, allergology, immunology and laboratory diagnostics. Deputy Minister of Health from 2024 to 2025.
Prof. dr hab. n. med. Marcin Czech
Professor of medical sciences and economics, Head of the Department of Pharmacoeconomics at the Institute of Mother and Child, President of the Polish Society of Pharmacoeconomics and former Deputy Minister of Health.
Dr n. biol. Aldona Chmielewska
Molecular and cell biologist, coordinator of the rare diseases group at the Association for Good Clinical Practice in Poland (GCPpl).
Pulmonary fibrosis cannot be reversed. Treatment slows disease progression, but lost lung function cannot be restored, making it essential to start treatment as early as possible. Yet in Poland, the average time to diagnosis of idiopathic pulmonary fibrosis is 12 months, and fewer than half of patients survive five years. Since 1 October 2026, low-dose CT screening for lung cancer has been a guaranteed benefit covered by Poland’s National Health Fund (NFZ), while treatment options are also expanding. Where do we lose the most time, and how can we use these new opportunities to diagnose and treat patients sooner?
Invited experts
Izabela Obarska
Healthcare-system expert in drug policy, reimbursement and access to therapies. From 2016 to 2017 she was Director of the Department of Drug Policy and Pharmacy at the Ministry of Health.
Prof. dr hab. n. med. Katarzyna Górska
Specialist in pulmonary and internal medicine, Deputy Head of the Department of Pulmonology, Internal Medicine, Oncological and Transplant Pulmonology at the National Medical Institute of the Ministry of the Interior and Administration in Warsaw. From 2002 to 2025 she worked clinically, academically and as a teacher at the Medical University of Warsaw. In 2025 she received the title of Professor of Medical and Health Sciences.
Katarzyna Romanowska-Próchnicka, MD, PhD
Specialist in rheumatology and internal medicine, assistant professor at the Medical University of Warsaw and senior assistant at the Department and Outpatient Clinic of Systemic Connective Tissue Diseases at the National Institute of Geriatrics, Rheumatology and Rehabilitation in Warsaw. She diagnoses and treats rheumatic diseases, including systemic connective tissue diseases such as systemic sclerosis and systemic lupus erythematosus.
Joanna Żuchowska, MD, PhD
Radiologist at the 2nd Department of Clinical Radiology, Central Clinical Hospital of the University Clinical Centre at the Medical University of Warsaw. Her work covers diagnostic imaging, including chest CT, which is important in diagnosing lung disease.
A patient sees a doctor at a public clinic, has tests at a private laboratory and undergoes surgery at a hospital owned by a large healthcare group. Providers are consolidating into ever larger groups, while millions of Poles pay both statutory health insurance contributions and private healthcare subscriptions. Who, in this system, takes responsibility for the patient’s entire course of care? Who will care for an ageing population? And can private healthcare be a profitable business while fulfilling its mission to patients?
Invited experts
Dr hab. n. med. Cezary Pakulski
Anaesthesiologist, intensive care specialist and emergency medicine specialist. Author of the book “System ochrony zdrowia w Polsce. Zdrowiu na ratunek” and co-author of numerous analyses of the healthcare system.
Marta Sobczyńska, MD, PhD
Dean of the Faculty of Medicine at Lazarski University and a paediatrician. She practises in both the public and private sectors. A graduate of an MBA in Healthcare, she has long been involved in developing standards of clinical quality and patient safety.
Lidia Niedźwiedzka-Owsiak
Member of the Management Board and Medical Director of the Great Orchestra of Christmas Charity Foundation, a co-founder who has been with the Foundation since its inception. Doctor honoris causa of the Poznań University of Medical Sciences, recognised for her contribution to the development of healthcare and her work to improve the quality of patient care.
Zbigniew Kowalski
Expert in medical communication and the doctor–patient relationship, lecturer at medical universities and trainer. Author of books and guides for physicians, and a member of the Polish Society of Medical Communication.
A procedure on promotion, a hair transplant, a vitamin drip, a package of tests without a referral — more and more medicine is chosen on a website and added to the basket like any other service. Price and “before and after” photographs often decide the choice. Who should qualify a patient for a procedure? How can a patient check who will perform it? And where is the line between a service and healthcare? The panel will also take account of this year’s reports from the Venus Academy of Aesthetic Medicine.
Invited experts
Prof. dr hab. n. med. Piotr Radziszewski
Head of the Department of General, Oncological and Functional Urology at the Medical University of Warsaw, specialist in urological oncology and da Vinci robotic surgery. Chair of the Venus Academy Jury, President of the Academic Urology Association and a member of the Scientific Council of the Oncology Centre.
Prof. dr hab. n. med. Artur Mamcarz
Specialist in internal medicine and cardiology, Head of the 3rd Department of Internal Medicine and Cardiology at the Medical University of Warsaw. For years he has focused on the modern treatment of cardiovascular disease and on educating doctors and patients in prevention.
Marcin Ambroziak, MD, PhD
Dermatologist with 25 years of experience, co-founder and Medical Director of Klinika Ambroziak. Co-chair of the aesthetic dermatology section of the Polish Dermatological Society and an international trainer in hyaluronic acid products.
For the Greatest Benefit to Humankind: What Defines True Medical Breakthrough Today?
The organiser reserves the right to amend the programme.
GALIEN FORUM 2026
Create your own graphic and invite your network to Galien Forum 2026.
Create your graphic
Join Galien Forum 2026. Attendance is free of charge. Registration is required.
Register now →Strategic Partner of Galien Forum
Knowledge Partners of Galien Forum
Galien Innovation Hub Partners
Honorary Patronage
Two pillars of Galien Forum
Strategic debates on the future of healthcare, new therapies, AI, reimbursement policy and the transformation of care systems.
Presentations of Polish medical innovations for experts, investors, industry partners and healthcare market leaders.
From Science to Society
Galien Forum is a meeting place for science, medicine, business and capital. We combine strategic debate on the future of healthcare with the presentation of Polish medical innovations to experts, investors and industrial partners actively involved in their development, funding and commercialisation.
We create a space where breakthrough ideas developed at universities, startups and research centres can find their path into clinical practice, the market and patients.
600+
participants
40+
speakers
1 day
of inspiration and debate
Three event stages
The main keynote space for strategic debates on the future of healthcare, the economics of innovation and healthcare system transformation.
A presentation space for selected Polish healthcare innovations, shown to experts, investors and market partners.
The final Forum venue, combined with the Prix Galien Poland distinctions ceremony for the most promising innovations.
Galien Innovation Hub
A platform connecting Polish medical innovations with international experts, investors and business partners.
Networking and media zone
During Galien Forum, the foyer of the Polish History Museum becomes a space for conversations, innovation presentations and professional media communication.
1:1 meetings
Coffee breaks, lunch, industry meetings and conversations that begin on stage and continue beyond it.
expert conversations
A dedicated space for interviews, recordings and expert conversations held during Galien Forum.
innovation zone
Selected teams presenting Polish healthcare innovations in dedicated showcase spaces.
The Galien Community
Galien Forum participants include leaders from the medical and innovation communities.
Clinicians and medical opinion leaders
Professors of medical and biomedical sciences
Practicing physicians, department heads and specialists implementing new technologies
Medical and technical universities and research teams
Representatives of the Ministry of Health
Research agencies and institutions: ABM, AOTMiT, NCBR
Patient organizations and healthcare system representatives
Representatives of pharma, biotech, medtech and digital health
Investors, funds and partners supporting innovation commercialization
The preliminary programme is now available. Register free of charge and join the leaders shaping tomorrow's healthcare.
Feel the atmosphere of Galien Forum